Get the Stockscreener App
1.10
7.84%
0.08
Pre-market:
1.12
0.02
+1.82%
Senseonics Holdings Inc stock is traded at $1.10, with a volume of 9.38M.
It is up +7.84% in the last 24 hours and up +41.50% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$1.02
Open:
$1.01
24h Volume:
9.38M
Relative Volume:
0.74
Market Cap:
$654.86M
Revenue:
$22.39M
Net Income/Loss:
$-60.39M
P/E Ratio:
-9.839
EPS:
-0.1118
Net Cash Flow:
$-70.51M
1W Performance:
+19.57%
1M Performance:
+41.50%
6M Performance:
+191.39%
1Y Performance:
+102.02%
1-Day Range:
$1.0035
$1.15
1-Week Range:
$0.903
$1.15
52-Week Range:
$0.25
$1.20
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Compare SENS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SENS
Senseonics Holdings Inc
|
1.10 | 654.86M | 22.39M | -60.39M | -70.51M | -0.1118 |
|
ABT
Abbott Laboratories
|
131.44 | 227.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.98 | 156.20B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
390.48 | 148.86B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.20 | 116.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.82B | 6.60B | 4.16B | 490.10M | 6.93 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Initiated | Jefferies | Underperform |
| Aug-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
| Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
| Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-23-19 | Initiated | Stifel | Buy |
| Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-29-19 | Initiated | Piper Jaffray | Neutral |
| Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
Peering Into Senseonics Holdings's Recent Short Interest - Benzinga
Let’s Talk About Wall Street’s Projection For Senseonics Holdings Inc (AMEX: SENS). - Marketing Sentinel
Senseonics files for Eversense 365 CE Mark registration - Medical Device Network
Senseonics (NYSE:SENS) Stock Price Up 9.4% – Time to Buy? - Armenian Reporter
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor - GlobeNewswire
Groundbreaking 365-Day Glucose Monitor Could Transform Diabetes Care in Europe - StockTitan
Senseonics (NYSE:SENS) Shares Gap DownHere's What Happened - MarketBeat
SENS stock soars to 52-week high, touches $0.93 amid robust gains - MSN
Senseonics (NYSE:SENS) Sets New 1-Year HighShould You Buy? - MarketBeat
Senseonics (NYSE:SENS) Trading Down 5%Should You Sell? - MarketBeat
Senseonics (NYSE:SENS) Sets New 52-Week HighStill a Buy? - MarketBeat
Senseonics (NYSE:SENS) Shares Up 8.4%What's Next? - MarketBeat
Senseonics (NYSE:SENS) Stock Price Up 8.4%Here's What Happened - MarketBeat
Senseonics (NYSE:SENS) Reaches New 52-Week HighHere's What Happened - MarketBeat
Continuous Glucose Monitoring Market is growing at a CAGR of 22% - openPR
Senseonics (NYSE:SENS) Reaches New 12-Month HighTime to Buy? - MarketBeat
Is Senseonics Holdings, Inc. (SENS) the Hottest Smid-Cap Stock So Far In 2025? - MSN
Senseonics Holdings (FRA:6L6) GF Value Rank : 0 (As of Jan. 20, 2025) - GuruFocus.com
Senseonics Holdings, Inc. Provides Business Updates and Preliminary Financial Information - Defense World
Senseonics (NYSE:SENS) Stock Price Down 4%What's Next? - MarketBeat
Senseonics Holdings' Metrics Potentially Highlight Launch-Driven Growth, Not Sustainability - Seeking Alpha
Senseonics (NYSE:SENS) Shares Down 4%Time to Sell? - MarketBeat
Senseonics director Anthony Raab resigns from board By Investing.com - Investing.com Australia
Senseonics director Anthony Raab resigns from board - Investing.com India
Senseonics (NYSE:SENS) Hits New 1-Year HighTime to Buy? - MarketBeat
Jane Street Group LLC Decreases Stake in Senseonics Holdings, Inc. (NYSE:SENS) - MarketBeat
United States Continuous Glucose Monitoring (CGM) Market - GlobeNewswire
SENS stock touches 52-week high at $0.76 amid robust gains - Investing.com Australia
Senseonics Holdings reports USD 8.3M revenue in Q4 2024 - Medical Buyer
Senseonics Holdings sees Q4 revenue of ~$8.3M - MSN
Senseonics Stock Surges 42% After Hours on Preliminary Revenue Report - Yahoo Finance
Geode Capital Management LLC Buys 179,103 Shares of Senseonics Holdings, Inc. (NYSE:SENS) - Defense World
Senseonics Holdings sees Q4 revenue of ~$8.3M (NYSE:SENS) - Seeking Alpha
Senseonics Holdings, Inc. Announces Business Updates - GlobeNewswire
Senseonics' Eversense CGM Doubles Patient Growth, Hits Record Shipments in Q4 2024 - StockTitan
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
Here’s Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
StockNews.com Begins Coverage on Senseonics (NYSE:SENS) - MarketBeat
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.38%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):